News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

Shoulder-up profile image of Professor Paul Workman in a black suit and black shirt
Drug discovery researcher Professor Paul Workman awarded prestigious AAAS Fellowship

31/01/23

Professor Paul Workman, former Chief Executive and President of The Institute of Cancer Research, London, from 2014 to 2021, has been elected as a Fellow of the American Association for the Advancement of Science (AAAS), one of the most distinguished honours in the scientific community.
blood sample test tubes
Experts call for better cancer tests to tailor treatment

30/01/23

Greater use of cancer tests is the key to tailoring use of new treatments for patients more precisely and so increasing their chances of being recommended for use within the NHS, experts say.
A train at Belmont station. Image credit: Dr Neil Clifton / CC BY-SA 2.0
Travel boost for The London Cancer Hub as number of trains set to double

27/01/23

The number of trains serving The London Cancer Hub’s local rail station, Belmont, is set to double thanks to £14m from the Government’s Levelling Up Fund.
Image shows a small round melanoma cell at the top and a big/flat melanoma cell underneath it
Cancer cells shrink or super-size to survive

25/01/23

Cancer cells can shrink or super-size themselves to survive drug treatment or other challenges within their environment, researchers have discovered.
ICR Logo
Scientists behind breast cancer gene discovery honoured with new plaques

25/01/23

The team of scientists who made a ground-breaking gene discovery which transformed the field of cancer research have been celebrated with the unveiling of two commemorative plaques in London today. The plaques pay homage to the 41 scientists who made the landmark discovery of the BRCA2 cancer gene at the ICR in 1995.
Christine O'Connell at the One More City cycling event
“A challenge for a challenge”: Meet the cyclists funding our secondary breast cancer research

20/01/23

Cyclist Christine O’Connell set up the One More City campaign shortly before she was diagnosed with stage 4 breast cancer in 2018. She and her teammates are now riding to fund a PhD studentship at The Institute of Cancer Research.
Breast Cancer Cells Credit Min Yu 547x410
Targeting cancer-supporting cells boosts immunotherapy in previously insensitive tumours

09/01/23

Removing a single protein from cells that surround tumours can improve the sensitivity of certain cancers to immunotherapy, researchers have found.
Proton Beam Therapy 547 x 410px
First UK proton beam therapy trial for breast cancer launches

03/01/23

The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched in the UK. The trial will compare proton beam therapy – which can target radiotherapy beams more precisely – with standard radiotherapy for patients who are at greater risk of long-term heart problems after radiotherapy treatment.
Prostate cancer cells
New targeted therapy using 'armed' antibodies shows promise against prostate cancer

28/12/22

A new type of treatment strategy targeting a protein found on the surface of the most lethal prostate cancers could hold promise against the disease.
ICR Logo
Twin study confirms childhood leukaemia starts in the womb and could help guide screening when only one twin is affected

20/12/22

By studying rare cases of identical twins with leukaemia, scientists have shed new light on the origins of the most common type of childhood cancer – confirming it originates in the womb but that events after birth determine whether or not clinical leukaemia develops.
Carols From Chelsea
Carols from Chelsea celebrates 20 years supporting our research

16/12/22

The Wren Chapel at the Royal Hospital Chelsea was full of guests and famous faces on 6 December, celebrating the 20th Carols from Chelsea service in support of The Institute of Cancer Research, London.
Fibroblasts - Ankur Singh, Georgia Tech
Scientific achievements of 2022

12/12/22

We have picked 10 exciting scientific discoveries from the past academic year that brilliantly showcase the quality, breadth and strategic impact of our research.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.